S. Kikuchi et al., EXPRESSION OF WILD-TYPE P53 TUMOR-SUPPRESSOR GENE AND ITS POSSIBLE INVOLVEMENT IN THE APOPTOSIS OF THYROID-TUMORS, SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 27(3), 1997, pp. 226-233
A good prognosis is often achieved in patients who have undergone trea
tment for human papillary carcinoma of the thyroid. On the assumption
that this may be partly attributable to an apoptotic tendency of this
special type of tumor, we measured DNA fragmentation, cell death by en
zyme-linked immunosorbent assay (ELISA), and the expression of apoptos
is related genes. DNA fragmentation occurred more extensively in malig
nant tumor cells than in benign thyroid tumors or normal thyroid tissu
e, as examined by agarose gel electrophoresis and confirmed by the qua
ntitative method using an ELISA kit. Although only expression of the t
umor suppressor gene, p53, was increased in the tumor tissue, no expre
ssion of other genes, such as Fas, TNF, c-myc, c-fos or bcl-2, was obs
erved in the normal, benign, or malignant tumor tissues, indicating th
at the roles of these gene functions, if any, were minimal in these ti
ssues. Since p53 is closely related to cellular apoptosis and no point
mutation was observed in the transcripts expressed by malignant cells
, apoptosis and/or the production of an angiogenesis inhibitor induced
by wild-type p53 molecules may be related to the favorable prognosis
of patients treated for papillary carcinoma of the thyroid.